Metrion Biosciences Ltd, a leading contract research organisation based in Great Britain, specialises in ion channel drug discovery and safety pharmacology. Founded in 2013, the company has rapidly established itself as a key player in the biotechnology sector, providing innovative solutions to pharmaceutical and biotech clients. With headquarters in Cambridge and operational reach across Europe and North America, Metrion offers a unique suite of services, including bespoke ion channel screening and advanced electrophysiology. Their commitment to scientific excellence and customer-focused approach has garnered recognition within the industry, positioning them as a trusted partner for drug development. Metrion's state-of-the-art technology and expertise in ion channel pharmacology set them apart, making significant contributions to the advancement of therapeutic research.
How does Metrion Biosciences Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Metrion Biosciences Ltd's score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Metrion Biosciences Ltd, headquartered in Great Britain, currently does not have publicly available carbon emissions data for recent years, as indicated by the absence of specific emissions figures. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the context of the biotechnology industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. While Metrion Biosciences Ltd has not disclosed specific commitments or targets, the industry trend suggests a growing emphasis on sustainability and environmental responsibility. As the company moves forward, it may consider establishing measurable climate commitments to align with global efforts in reducing greenhouse gas emissions and contributing to a more sustainable future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Metrion Biosciences Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.